During the past decade, Aichi Cancer Center Hospital ( Site 0803) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Aichi Cancer Center Hospital ( Site 0803)" are "Carcinoma, Non-squamous Non-small-cell Lung" (1 trials) and "Carcinoma, Squamous Cell, Non-small-cell Lung" (1 trials). Many other conditions were trialed in "Aichi Cancer Center Hospital ( Site 0803)" in a lesser frequency.

Most popular intervention types in "Aichi Cancer Center Hospital ( Site 0803)" are "Biological" (2 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (2 trials), "Olaparib" (2 trials), "Pembrolizumab" (2 trials), "Cisplatin" (1 trials) and "Nab-paclitaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Aichi Cancer Center Hospital ( Site 0803)" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Aichi Cancer Center Hospital ( Site 0803)". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Aichi Cancer Center Hospital ( Site 0803), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Aichi Cancer Center Hospital ( Site 0803), 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".